Integra LifeSciences Announces Appointment of Mojdeh Poul as President and Chief Executive Officer

Core Viewpoint - Integra LifeSciences Holdings Corporation has appointed Mojdeh Poul as the new president and CEO, effective January 6, 2025, succeeding Jan De Witte, who will remain in his role until that date [1][2]. Group 1: Leadership Transition - Mojdeh Poul brings extensive experience in global healthcare, having previously served as executive vice president and group president for 3M's $8.5 billion Global Healthcare Business, overseeing R&D, manufacturing, and commercial operations [2]. - Poul has a proven track record in business strategy, transformation, and leadership development, which is expected to be critical for Integra's strategic and operational plans [2][3]. - Jan De Witte is recognized for his contributions to Integra, particularly in growing the international business and integrating digital technology into the product pipeline [5]. Group 2: Company Background - Integra LifeSciences is focused on restoring patients' lives through innovative treatment pathways and aims to set new standards in surgical, neurologic, and regenerative care [6]. - The company has a comprehensive portfolio of high-quality leadership brands and has been a pioneer in medical innovations for 35 years [6].